Ghost Tree Capital’s Chinook Therapeutics KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-100,000
Closed -$4.65M – 62
2018
Q1
$4.65M Buy
+100,000
New +$3.66M 0.94% 34
2017
Q2
– Sell
-160,000
Closed -$8.6M – 80
2017
Q1
$8.6M Buy
+160,000
New +$9.04M 1.6% 25

Other funds holding KDNY

Ghost Tree Capital's KDNY Position: Q2 2018 in Review

Ghost Tree Capital sold out of Chinook Therapeutics (KDNY) in Q2 2018, closing a stake of 100,000 shares — an estimated $4.65M sold.

Ghost Tree Capital first reported a position in KDNY in Q1 2017 and held it in 2 quarters. The position peaked at $8.6M in Q1 2017. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2018.

  • Ghost Tree Capital reported no remaining Chinook Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Ghost Tree Capital sold 100,000 Chinook Therapeutics shares in Q2 2018, an estimated $4.65M.
  • Ghost Tree Capital first reported a position in Chinook Therapeutics in Q1 2017 and held it in 2 quarters.
  • Ghost Tree Capital's Chinook Therapeutics position peaked at $8.6M in Q1 2017.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics as of Q2 2018.

Based on Ghost Tree Capital's 13F filing for Q2 2018, filed 14 Aug 2018.